Bayesian modelling of healthcare resource use in multinational randomized clinical trials

PharmacoEconomics

Volumn 27, Issue 12, 2009, Pages 1017-1029

  Gauthier, Aline ^a   Manca, Andrea ^b   Anton, Susan ^c  

^a i3 Innovus   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BAYES THEOREM; CHRONIC RESPIRATORY TRACT DISEASE; CLINICAL STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZATION; RESOURCE ALLOCATION; THEORETICAL MODEL;

BAYES THEOREM; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS; INTERNATIONAL COOPERATION; MODELS, ECONOMETRIC; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 73549100216     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11314030-000000000-00000     Document Type: Article

References (35)

1. Sculpher MJ, Claxton K, Drummond M, et al. Whither trial-based economic evaluation for health care decision making? Health Econ 2006; 15: 677-687
2. Sculpher MJ, Pang FS, Manca A, et al. Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess 2004; 8: iii-192
3. Manca A, Willan AR. 'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data. Pharmacoeconomics 2006; 24 (11): 1101-1119
4. Drummond M, Manca A, Sculpher M. Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies. Int J Technol Assess Health Care 2005; 21: 165-171
5. Willan AR, Kowgier ME. Cost-effectiveness analysis of a multinational RCT with a binary measure of effectiveness and an interacting covariate. Health Econ 2008; 17: 777-791
6. Manca A, Rice N, Sculpher MJ, et al. Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models. Health Econ 2005; 14: 471-485
7. Grieve R, Nixon R, Thompson SG, et al. Using multilevel models for assessing the variability of multinational resource use and cost data. Health Econ 2005; 14: 185-196
8. Grieve R, Nixon R, Thompson SG, et al. Multilevel models for estimating incremental net benefits in multinational studies. Health Econ 2007; 16: 815-826
9. Nixon RM, Thompson SG. Methods for incorporating covariate adjustment, subgroup analysis and betweencentre differences into cost-effectiveness evaluations. Health Econ 2005; 14: 1217-1229
10. Willke RJ, Glick HA, Polsky D, et al. Estimating countryspecific cost-effectiveness from multinational clinical trials. Health Econ 1998; 7: 481-493
11. Wordsworth S, Ludbrook A. Comparing costing results in across country economic evaluations: the use of technology specific purchasing power parities. Health Econ 2005; 14: 93-99
12. Jonsson B, Weinstein MC. Economic evaluation alongside multinational clinical trials: study considerations for GUSTO IIb. Int J Technol Assess Health Care 1997; 13: 49-58
13. Thompson SG, Nixon RM, Grieve R. Addressing the issues that arise in analysing multicentre cost data, with application to a multinational study. J Health Econ 2006; 25: 1015-1028
14. Cameron AC, Trivedi PK. Regression analysis of count data. New York: Cambridge University Press, 1998
15. McCullagh P, Nelder J. Generalized linear models, 2nd ed. [monographs on statistics and applied probability]. New York: Chapman and Hall, 1989
16. Metcalfe C, Thompson SG. The importance of varying the event generation process in simulation studies of statistical methods for recurrent events. Stat Med 2006; 25: 165-179
17. Gelman A, Carlin J, Stern H, et al. Bayesian data analysis. New York: Chapman and Hall/CRC, 2004
18. Glick H, Doshi JA, Sonnad SS, et al. Economic evaluation in clinical trials. Oxford: Oxford University Press, 2007
19. Ohlssen DI, Sharples LD, Spiegelhalter DJ. Flexible random-effects models using Bayesian semi-parametric models: applications to institutional comparisons. Stat Med 2007; 26: 2088-2112
20. Ghosh S, Mukhopadhyay P, Lu J. Bayesian analysis of zero inflated regression models. J Stat Planning Infer 2006; 136: 1360-1375
21. Spiegelhalter D, Thomas A, Best N, et al. WinBUGS user manual: version 1.4. Cambridge: MRC Biostatistics Unit, 2003
22. Getzen TE. Aggregation and themeasurement of health care costs. Health Serv Res 2006; 41: 1938-1954
23. Rubin D. Multiple imputation for nonresponse in surveys, New York. New York: John Wiley & Sons, 1987
24. Schafer J. Analysis of incomplete multivariate data. New York: Chapman and Hall, 1997
25. Martin A. Bayesian inference for heterogeneous event counts. Sociol Methods Res 2003; 31: 30-63
26. Spiegelhalter D, Best N, Carlin B, et al. Bayesian measures of model complexity and fit: series B (statistical methodology). J R Stat Soc 2002; 64: 583-639
27. Petrinco M, Pagano E, Desideri A, et al. Information on center characteristics as costs' determinants in multicenter clinical trials: is modeling center effect worth the effort? Value Health 2008; 12 (2): 325-330
28. Spiegelhalter D, Abrams K,Miles J. Bayesian approaches to clinical trials and health care evaluation. Hoboken (NJ): John Wiley & Sons, 2004
29. Sangho M, Jaeun S. Health care utilization among Medicare- Medicaid dual eligibles: a count data analysis. BMC Public Health 2006 1988; 6: 88
30. Nixon RM, Thompson SG. Parametric modelling of cost data in medical studies. Stat Med 2004; 23: 1311-1331
31. Briggs A, Nixon R, Dixon S, et al. Parametric modelling of cost data: some simulation evidence. Health Econ 2005; 14: 421-428
32. Conti S, Manca A, Lambert P, et al. Bayesian multivariate modelling of patient level healthcare resource use data in RCTs [abstract]. International Health Economics Association (iHEA); 2007 Jul 9; Copenhagen
33. Lambert PC, Billingham LJ, Cooper NJ, et al. Estimating the cost-effectiveness of an intervention in a clinical trial when partial cost information is available: a Bayesian approach. Health Econ 2008; 17: 67-81
34. Moerbeek M. The consequence of ignoring a level of nesting in multilevel analysis. Multivar Behav Res 2004; 39: 149
35. Wennberg J, Gittelsohn J. Small area variations in health care delivery. Science 1973; 182: 1102-1108